Latest papers

Prognostic factors and scores in post-transplantation lymphoproliferative disorders after solid organ transplantation.

Primary central nervous system post-transplantation lymphoproliferative disorder.

Treatment advances in posttransplant lymphoproliferative disease.

Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease?

Post-transplant lymphoproliferative disorders in liver transplanted patients: a single-centre experience.

The acquired deficiency of C1-inhibitor: lymphoproliferation and angioedema.

[Lung involvement in lymphoid and lympho-plasmocytic proliferations (except lymphomas)].

Immunotherapy for Epstein-Barr virus-associated malignancies.

Of lymphocytes and cutaneous epithelium: keratoacanthomatous hyperplasia in CD30+ lymphoproliferative disorders and CD30+ cells associated with keratoacanthoma.

Hematopoietic stem cell transplantation after posttransplant lymphoproliferative disorder.

Extramedullary plasmocytoma: a rare case with bifocal manifestation at uncommon sites.

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells.

Adhesive interactions regulate transcriptional diversity in malignant B cells.

Functional classification of peripheral T-cell lymphomas as an approach to improve outcome prediction and therapy selection.

Chronic lymphoproliferative disorder of natural killer cells: a distinct entity with subtypes correlating with normal natural killer cell subsets.

Clinical characteristics of monomorphic post-transplant lymphoproliferative disorders.

Head and neck malignancies in Croatian renal transplant recipients.

[Primary cutaneous CD30+ lymphoproliferative disorders].

EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression.

Targeted therapy in haematological malignancies.